Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharm-country symbols : Krys save search
Krystal Biotech Announces Clinical Data on Topical Application of B-VEC to the Eye to Treat Ocular Complications in a Patient with Dystrophic Epidermolysis Bullosa Under a Compassionate Use Program
Published: 2023-04-24 (Crawled : 12:00) - biospace.com/
KRYS | $158.63 -3.26% -3.37% 340K
|
Health Technology
|
| O: 0.08%
H: 0.31%
C: -2.21%
biotech ocular eye application program
Krystal Biotech to Present at Association for Research in Vision and Ophthalmology Annual Meeting
Published: 2023-04-13 (Crawled : 12:00) - biospace.com/
KRYS | $158.63 -3.26% -3.37% 340K
|
Health Technology
|
| O: 0.0%
H: 6.92%
C: 6.62%
biotech association research meeting
Krystal Biotech Announces FDA’s 3-Month Extension of BLA PDUFA Date and Regulatory Update for B-VEC to Treat Patients with Dystrophic Epidermolysis BullosaNEW PDUFA DATE OF MAY 19, 2023
Published: 2023-01-09 (Crawled : 22:00) - biospace.com/
KRYS | $158.63 -3.26% -3.37% 340K
|
Health Technology
|
| O: -5.18%
H: 0.0%
C: -6.05%
pdufa biotech extension update
Krystal Biotech Announces Second Quarter 2022 Financial Results and Reports Updates on Operational Progress
Published: 2022-08-08 (Crawled : 12:00) - biospace.com/
KRYS | $158.63 -3.26% -3.37% 340K
|
Health Technology
|
| O: -0.04%
H: 3.71%
C: 0.41%
biotech results
Krystal Biotech to Present at Goldman Sachs 43rd Annual Global Healthcare Conference
Published: 2022-06-07 (Crawled : 12:00) - biospace.com/
KRYS | $158.63 -3.26% -3.37% 340K
|
Health Technology
|
| O: -1.83%
H: 3.51%
C: 2.82%
conference biotech
Krystal Biotech Announces First Quarter 2022 Financial Results and Reports Updates on Operational Progress
Published: 2022-05-09 (Crawled : 01:00) - biospace.com/
KRYS | $158.63 -3.26% -3.37% 340K
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
biotech results
Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study
Published: 2022-04-11 (Crawled : 16:00) - biospace.com/
KRYS | $158.63 -3.26% -3.37% 340K
|
Health Technology
|
| O: -1.1%
H: 1.84%
C: 0.79%
label biotech
Krystal Biotech Appoints Jing Marantz, MD, PhD, MBA as Chief Business Officer and Rand Sutherland, MD, MPH to its Board of Directors
Published: 2022-01-18 (Crawled : 22:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.98%
H: 0.0%
C: 0.0%
KRYS | $158.63 -3.26% -3.37% 340K
|
Health Technology
|
| O: -0.31%
H: 0.21%
C: -4.33%
ARCT 4 | $25.995 -1.23% -1.25% 630K
|
Health Technology
|
| O: -3.43%
H: 0.0%
C: -15.84%
biotech iot
Krystal Biotech to Present at the Chardan 5th Annual Genetic Medicines Conference
Published: 2021-10-01 (Crawled : 00:20) - biospace.com/
KRYS | $158.63 -3.26% -3.37% 340K
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
genetic biotech iot conference
Krystal Biotech Receives Approval from the Human Research Ethics Committee in Australia for Phase 1 Trial of KB407 for Cystic Fibrosis
Published: 2021-09-29 (Crawled : 14:00) - biospace.com/
KRYS | $158.63 -3.26% -3.37% 340K
|
Health Technology
|
| O: 1.07%
H: 0.25%
C: -3.55%
fibrosis phase 1 biotech research iot trial approval cystic fibrosis
Krystal Biotech Appoints Andy Orth as Chief Commercial Officer
Published: 2021-05-03 (Crawled : 14:15) - biospace.com/
KRYS | $158.63 -3.26% -3.37% 340K
|
Health Technology
|
| O: 1.98%
H: 2.2%
C: -4.95%
biotech iot commercialization
Krystal Biotech Provides Updates from its Rare Genetic Lung Disease Pipeline
Published: 2021-04-19 (Crawled : 13:00) - biospace.com/
KRYS | $158.63 -3.26% -3.37% 340K
|
Health Technology
|
| O: -1.11%
H: 0.34%
C: -2.29%
disease genetic biotech iot rare
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.